Santa Monica-based nootropics producer TruBrain is expanding into the CBD marketplace with a new product that combines its patent-pending smart drug formula with the increasingly popular hemp extract.
To help finance this expansion, the company launched a crowdfunding campaign that offers an ownership stake in the business to everyday investors. The goal of the campaign, which is hosted on the StartEngine platform, is to raise $1 million in new capital.
Trubrain previously raised $1.6 million from venture capital firms and angel investors, and reached profitability earlier this year, surpassing $12 million in lifetime sales of its cognitive enhancement products.
“Our mission is to help people do their best thinking - that’s why we are excited about CBD," founder and CEO Chris Thompson told Benzinga. "Our preliminary research has shown that CBD has a unique ability to block stress and anxiety, paving the way for TruBrain nootropics to deliver the most dramatic outcomes of mental endurance and break through procrastination.”
Related Links:
NBA Vet Turned Cannabis Exec Al Harrington Talks $16M Funding Round, Social Equity
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!